Cargando…
A Phase III clinical study to evaluate the efficacy of combined azithromycin and dexamethasone in the treatment of blepharoconjunctivitis
PURPOSE: The purpose of this study was to evaluate the clinical and antimicrobial efficacy and safety of ISV-502 (1.0% azithromycin and 0.1% dexamethasone) compared to 1.0% azithromycin or 0.1% dexamethasone in the treatment of subjects with blepharoconjunctivitis. PATIENTS AND METHODS: Patients wit...
Autores principales: | Hosseini, Kamran, Hutcheson, Judith, Lindstrom, Richard L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829621/ https://www.ncbi.nlm.nih.gov/pubmed/24250221 http://dx.doi.org/10.2147/OPTH.S52474 |
Ejemplares similares
-
A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin–0.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment of subjects with blepharitis
por: Hosseini, Kamran, et al.
Publicado: (2016) -
Dupilumab-associated blepharoconjunctivitis
por: Paulose, Sefy A., et al.
Publicado: (2019) -
Monkeypox Presenting with Blepharoconjunctivitis
por: Bloom, Jeffrey, et al.
Publicado: (2023) -
Dupilumab-Associated Blepharoconjunctivitis with Giant Papillae
por: Vingopoulos, Filippos, et al.
Publicado: (2020) -
Unilateral Blepharoconjunctivitis due to Monkeypox Virus Infection
por: Scandale, Pierluigi, et al.
Publicado: (2022)